THE carcinogenic action of dialkylnitrosamines and related compounds has been believed to be related to their alkylation of nucleic acid bases and possibly of other cellular macromolecules, the alkylating moiety being released in the course of the oxidative metabolism of these compounds (Magee and Barnes, 1967; Druckrey, Preussmann and Ivankovic, 1969). However, in subsequent studies, many workers found that the degree of alkylation of nucleic acid bases in various organs, by various nitroso compounds other than dimethylnitrosamine (DMN), did not correlate with the localization of tumours induced by the respective compounds (Schoental, 1967; Magee, 1968, 1971; Lijinsky et al., 1972; Goth and Rajewsky, 1972, and others) . A possibility that the mono alkylnitrosamino moiety may be involved in the biological actions of nitrosamines has been considered by Heath (1962) and rejected.
It is unfortunate that DMN has been used mainly in studies of the mechanism of action of nitrosamines; oxidation of the a carbon leads to very unstable intermediates, which decompose with the release of nitrogen, and an alkylating moiety. Moreover, when searching for the alkylated bases the nucleic acids have often been subjected to strong acid hydrolysis, a procedure which might decompose addition and other product(s) which may be also present in the isolated nucleic acid fractions.
The ethyl homologue, diethylnitrosamine (DEN), is a much less damaging agent for the liver, though very effective as a carcinogen. It may be significant that the degree of ethylation of nucleic acid bases occurs to a much lesser extent than the respective methylations (Goth and Rajewsky, 1972) . (The ratio is 1/30 to 1/100.)
The involvement of the nitrosamino moiety has been suggested also as regards the mutagenic action of nitroso compounds (Rosenkranz, Rosenkranz and Schmidt, 1969) . The problem has been discussed fully by Magee, who concluded: "It is possible that the nitroso compounds owe their biological activity to these alkylation reactions, but this is not established, and other cellular interactions may be involved " (Magee, 1969) .
I suggest that the carcinogenic action of alkylnitrosamines (A) is mediated by their respective alkylnitrosamino aldehydes (C), which may be intermediate oxidation products between the alcoholic (B) and carboxylic (D) metabolites (Fig.  1) . Such metabolic aldehydes would resemble in action the alkylnitrosourethanes (Schoental, 1966) .
The evidence that the alkylnitrosamino moiety can survive metabolic oxidation is based on the published results of metabolic studies. Already in 1964, polar metabolites which retained the nitrosamino moiety had been detected in the urine of rats given a large dose (1000 mg/kg body weight) of dibutylnitrosamine (Druckrey et al., 1964) . More recently, Okada and Suzuki (1972) identified butyl(3-carboxypropyl)nitrosamine and butyl(3-carboxy-2-hydroxypropyl)nitrosamine as the main urinary metabolites of the bladder carcinogen, butyl(4-hydroxybutyl)nitrosamine, in the rat. The evidence that the alkylnitrosamino moiety can survive metabolic oxidation has been confirmed in the case of several symmetrical dialkylnitrosamines, having C2 to C5 carbons in the alkyl chains. Among the rat urinary metabolites of these compounds products of w oxidation of the alkyls in the form of hydroxylic and carboxylic derivatives have been identified. In the case of di-n-pentylnitrosamine, shortening of an alkyl chain occurred; one of its metabolites was identified as 7N-n-pentyl-N-nitroso-N-npropionic acid (Blattmann and Preussmann, 1973) .
The fact that alcoholic and carboxylic nitrosamino metabolites are excreted in the urine suggests that the respective aldehydo and keto derivatives, which would be expected to be formed by the action of alcohol dehydrogenase (an enzyme known to be present mainly in the liver and in the kidneys) should be also searched for. However (Schoental, 1966) . A hypothetical scheme of interaction of the aldehydic derivatives with chromatin is represented in Fig. 2 conditions under which such interactions could take place: the relevant part of the nucleic acid base must be accessible and the particular sulphur containing nucleohistones, or other specific protein, must be in reduced form at the time of encounter with the activated molecule of the carcinogen. The spatial distribution of the specific reactive centres in chromatin and their accessibility (Mirsky, 1971) probably determine that only compounds of appropriate size and geometry, and having apposite functional groups, could fit and interact with it in a concerted manner. When bulky substituents are present, e.g. R' tert-butyl, steric factors may prevent the formation of such a bridge. Similarly, when the alkyls are long chains, as in the case of n-dibutylnitrosamine, these have to undergo appropriate shortening by decarboxylation of one of their oxidized alkyls before the compound can react and fit into the critical space. (Hence its carcinogenic action becomes apparent in the bladder.)
The polar, water soluble, metabolites are excreted mostly in the form of the non carcinogenic glucuronides; the part that is carried in the blood stream in unconjugated form can exert carcinogenic action only at sites where their concentration overcomes their unfavourable distribution characteristics and allows enough of the compound to penetrate into the cells, e.g. in the kidney or in the bladder.
Some of the metabolites are indeed known to be carcinogenic, though not toxic even in large doses. According to Magee and Barnes (1967) for rats, the LD50 of N-nitrosodiethylamine is 216 mg/kg body weight, while that of Nnitroso -ethyl -2 -hydroxyethylamine is more than 7500 mgfkg; the LD50 of NV-nitroso-di-n-butylamine is 1200 mg/kg while that of N-nitrosobutyl-4-hydroxybutylamine is 1800 mg/kg body weight.
It may be significant that the glucoside, cycasin, has to be hydrolysed in order to exert carcinogenic action (Laqueur and Spatz, 1968) ; its aglycone, methylazoxymethanol, Ci3-N NN CH20H 0 would be expected to undergo oxidation to methylazoxyformaldehyde and react at similar cellular sites, in a similar manner, to the aldehydic derivatives of nitrosamines.
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